Tissue transglutaminase (TG2) is implicated in regulation of cell attachment, interactions of the cells with the surrounding ECM, motility, invasion and is considered as a bad prognostic factor in different cancers, including PaCa [50], [56], [57], [58]. Here, TGM2 is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.